Anticoagulants are blood thinning medications that are used for the treatment and prevention of blood clots. They act mainly by slowing blood clot formation and thus preventing associated complications1.Their approved Food and Drug Administration (FDA) indications include prophylaxis and treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE) and preventing complications associated with atrial fibrillation such as stroke2. For the past years, vitamin-k antagonist (warfarin) has been the primary treatment for a wide range of coagulation related indications3. However, limitations of warfarin have led to the discovery of a new generation of anticoagulants. Some limitations of warfarin use include a narrow therapeutic index, daily monitoring
